Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Lenvatinib starting dose and dose reduction.
| Lenvatinib | No. of Patients (%) |
|---|---|
| Starting dose (once daily) | |
| 24 mg | 9 (39.1) |
| 20 mg | 7 (30.4) |
| 18 mg | 2 (8.9) |
| 14 mg | 5 (21.7) |
| Dose reduction on treatment (if started on) | |
| 24 mg | 4/9 (44.4) |
| 20 mg | 3/7 (42.9) |
| 18 mg | 0/2 (0) |
| 14 mg | 1/5 (20.0) |
| Reason for discontinuation | |
| Continues on treatment | 4 (17.4) |
| Toxicity | 4 (17.4) |
| Progressive disease | 15 (65.2) |
